These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15017692)

  • 21. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
    Cheng G; Li Y; Tian F
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
    Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
    Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
    Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
    Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas].
    Qin F; Qin X; Zhang X; Jia HW
    Ai Zheng; 2002 Feb; 21(2):167-70. PubMed ID: 12479068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues].
    Zuo WS; Wei L; Song XR; Wang XW; Wang MY; Wang YS; Yu ZY; Bi Y
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3142-5. PubMed ID: 17313768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma.
    Yang W; Zeng X; Chen C; Chen Z; Du G
    J Tongji Med Univ; 2000; 20(4):311-4. PubMed ID: 12840920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene (mrp) and mdr-1/p170 expression in acute leukemia].
    Zhao Y; Yu L; Lou F; Wang Q; Pu J; Zhou Q
    Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):760-3. PubMed ID: 11798719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
    Zhao M; Yu S; Zhang M
    Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].
    Han B; Liao M; Su J; Feng J; Wang E; Dong Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):727-31. PubMed ID: 12622891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma.
    Schwarzenbach H
    Med Oncol; 2002; 19(2):87-104. PubMed ID: 12180485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
    Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
    J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02].
    Li J; Xu L; He K
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):288-91. PubMed ID: 11721384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
    Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
    Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between expression of multidrug-resistant genes in nasopharyngeal carcinoma tissue and sensitivity to chemotherapy].
    Tao ZQ; Liu SC; Si YF; Zhang Z; Zhou XZ; Deng ZX; Zhou RJ; Huang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Mar; 40(3):203-7. PubMed ID: 15952572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of multidrug resistance-related markers in gastric cancer.
    Fan K; Fan D; Cheng LF; Li C
    Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
    Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
    Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
    Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
    Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.